BioMed Realty Trust Announces Public Offering

BioMed Realty Trust, Inc.

today announced it has commenced a public offering of 13,500,000 shares of its common stock pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. BioMed expects to use the net proceeds of the offering to fund a portion of the purchase price of recently announced acquisitions, repay a portion of the outstanding indebtedness under its $720.0 million unsecured line of credit and for other general corporate and working capital purposes. All of the shares will be offered by the company. BioMed also expects to grant the underwriters a 30-day option to purchase an additional 2,025,000 shares to cover over-allotments, if any. Wells Fargo Securities, LLC, Raymond James & Associates, Inc., Morgan Stanley & Co. Incorporated and UBS Securities LLC are the joint book-running managers, and Deutsche Bank Securities Inc. and KeyBanc Capital Markets Inc. are co-lead managers for the offering.